High Tower Advisors, LLC Celcuity Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$11.96 - $19.35 $366,286 - $592,613	-30,626 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$17.35 - $24.87 $1,735 - $2,487	-100 Reduced 0.33%	30,626 $551,000
Q2 2021 Aug 06, 2021	BUY	$14.25 - $30.93 $1,425 - $3,093	100 Added 0.33%	30,726 $737,000
Q4 2020 Feb 10, 2021	SELL	$5.13 - $11.72 $51,300 - $117,200	-10,000 Reduced 24.61%	30,626 $281,000
Q3 2018 Nov 09, 2018	BUY	$20.96 - $30.77 $851,520 - $1.25 Million	40,626 New	40,626 $1.17 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.